Detalhe da pesquisa
1.
Cardiovascular Screening Practices and Statin Prescription Habits in Patients with Psoriasis among Dermatologists, Rheumatologists and Primary Care Physicians.
Acta Derm Venereol
; 103: adv5087, 2023 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36987537
2.
Genetic Influence on Treatment Response in Psoriasis: New Insights into Personalized Medicine.
Int J Mol Sci
; 24(12)2023 Jun 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37372997
3.
Tildrakizumab-induction therapy followed by as-needed dosing in patients with mild-to-moderate psoriasis.
Clin Exp Dermatol
; 49(3): 272-273, 2024 Feb 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37878574
4.
Monocyte-to-High-Density Lipoprotein Ratio Is Associated with Systemic Inflammation, Insulin Resistance, and Coronary Subclinical Atherosclerosis in Psoriasis: Results from 2 Observational Cohorts.
J Invest Dermatol
; 2024 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38460808
5.
Early Detection and Progression of Subclinical Atherosclerosis in Psoriasis (EDSAP): protocol for an observational, single-centre, prospective cohort study.
BMJ Open
; 13(9): e072455, 2023 09 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37751953
6.
Association of the Complement System with Subclinical Atherosclerosis in Psoriasis: Findings from an Observational Cohort Study.
J Invest Dermatol
; 2023 Nov 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38036288
7.
Rapid resolution of guttate psoriasis without recurrence for one year following two doses of guselkumab.
Int J Dermatol
; 63(4): 534-535, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38305493